Gerald Wulf

14.1k total citations · 1 hit paper
152 papers, 5.3k citations indexed

About

Gerald Wulf is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Gerald Wulf has authored 152 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 46 papers in Hematology and 40 papers in Pathology and Forensic Medicine. Recurrent topics in Gerald Wulf's work include Lymphoma Diagnosis and Treatment (39 papers), CAR-T cell therapy research (27 papers) and Hematopoietic Stem Cell Transplantation (22 papers). Gerald Wulf is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), CAR-T cell therapy research (27 papers) and Hematopoietic Stem Cell Transplantation (22 papers). Gerald Wulf collaborates with scholars based in Germany, United States and Switzerland. Gerald Wulf's co-authors include Margaret A. Goodell, Malcolm K. Brenner, Thomas Jax, Jed G. Nuchtern, Angela E. Foster, U. Göbel, Karim Nayernia, Wolfgang Engel, Jae Ho Lee and Bjoern Chapuy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gerald Wulf

136 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A distinct “side population” of cells with high drug efflux capacity in human tumor cells

2004 1.0k citations Gerald Wulf et al. profile →

Peers

Countries citing papers authored by Gerald Wulf

Since Specialization

Citations

This map shows the geographic impact of Gerald Wulf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Wulf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Wulf more than expected).

Fields of papers citing papers by Gerald Wulf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Wulf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Wulf. The network helps show where Gerald Wulf may publish in the future.

Co-authorship network of co-authors of Gerald Wulf

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Wulf. A scholar is included among the top collaborators of Gerald Wulf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Wulf. Gerald Wulf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party 2025 ·Leukemia ·Olaf Penack, (unknown), Christophe Peczynski, (unknown), (unknown), Nicolaus Kröger, Igor Wolfgang Blau, Didier Blaise, Jaime Sanz, Matthias Eder, Hakan Özdoğu, Dominik Schneidawind, Annoek E. C. Broers, Gerald Wulf, Alberto Mussetti, Ivan Moiseev, Charlotte Graham, Hélène Schoemans, Zinaida Perić	0
2	Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden 2025 ·Blood Advances ·(unknown), (unknown), (unknown), Franziska Brünner, (unknown), Mathias Haenel, Igor Age Kos, (unknown), Georg Lenz, (unknown), J. Schneider, Christian Schultze‐Florey, Evgenii Shumilov, Thomas Weber, Gerald Wulf, Vladan Vučinić, Dimitrios Mougiakakos	0
3	Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe 2024 ·Cancer Medicine ·(unknown), Gerald Wulf, (unknown), Ulrike Bacher, Mathias Rummel, (unknown), Andrea Kerkhoff, (unknown), Thomas Melchardt, Thomas Pabst, Georg Lenz, Evgenii Shumilov	1
4	Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation 2024 ·American Journal of Hematology ·Nico Gagelmann, (unknown), (unknown), (unknown), Matthias Stelljes, Igor Wolfgang Blau, Arne Brecht, Wolfgang Bethge, Thomas Schroeder, Gerald Wulf, Elisa Sala, Gesine Bug, Katharina Fleischhauer, Nicolaus Kröger, (unknown)	2
5	Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study 2024 ·HemaSphere ·(unknown), Evgenii Shumilov, (unknown), (unknown), Andrea Kerkhoff, (unknown), Christian Reicherts, (unknown), (unknown), Michèle J. Hoffmann, Urban Novak, Michael Daskalakis, Norbert Schmitz, Matthias Stelljes, Gerald Wulf, Ulrike Bacher, Georg Lenz, Thomas Pabst	16
6	Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning 2024 ·Leukemia & lymphoma ·Evgenii Shumilov, Lewis J. Levien, (unknown), Wolfram Jung, Andreas Leha, Raphael Koch, Justin Hasenkamp, Gerald Wulf	0
7	Low incidence and morbidity of Epstein‐Barr virus reactivation following donor lymphocyte infusions 2023 ·SHILAP Revista de lepidopterología ·(unknown), Justin Hasenkamp, Wolfram Jung, (unknown), J.H. Maas, Gerald Wulf	0
8	Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis 2023 ·Transplantation and Cellular Therapy ·(unknown), Wolfgang Bethge, (unknown), (unknown), Bastian von Tresckow, Francis Ayuk, Olaf Penack, Vladan Vučinić, Malte von Bonin, Claudia D. Baldus, Dimitrios Mougiakakos, Gerald Wulf, Ulf Schnetzke, Matthias Stelljes, Matthias Fante, Roland Schroers, Nicolaus Kroeger, Peter Dreger	8
9	Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study 2023 ·Blood Advances ·Maria‐Luisa Schubert, Wolfgang Bethge, Francis Ayuk, Malte von Bonin, Vladan Vučinić, Eva Wagner-Drouet, Marion Subklewe, Claudia D. Baldus, Bertram Glaß, Reinhard Marks, Dimitrios Mougiakakos, Roland Schroers, Matthias Stelljes, Max S. Topp, Gerald Wulf, Nicolaus Kröger, Peter Dreger	9
10	Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients 2023 ·HemaSphere ·(unknown), (unknown), Nicole Seifert, Deepak Vangala, (unknown), Sabine Seidel, Thomas Mika, (unknown), (unknown), (unknown), (unknown), Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Bjoern Chapuy	2
11	Cardiovascular and Metabolic Determinants of Quality of Life in Patients with Cancer 2022 ·ESC Heart Failure ·Ruben Evertz, (unknown), (unknown), Miroslava Valentová, (unknown), Friederike Braulke, Gerald Wulf, Tobias R. Overbeck, Annalen Bleckmann, Alexander König, (unknown), (unknown), Sara Hadzibegovic, Alessia Lena, Ulrich Keller, Ulf Landmesser, Andreas Schuster, Markus S. Anker, Gerd Hasenfuß, Stephan von Haehling	4
12	Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party 2020 ·Bone Marrow Transplantation ·Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, (unknown), Hélène Labussière‐Wallet, (unknown), Dietrich W. Beelen, Jan J. Cornelissen, Gerald Wulf, Pavel Jindra, Hervé Tilly, Jakob Passweg, (unknown), Gesine Bug, Christoph Schmid, Arnon Nagler, Sebastian Giebel, Mohamad Mohty	14
13	Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H‐Ferritin 2018 ·Journal of Neurochemistry ·Vivek Venkataramani, Thorsten R. Doeppner, Desiree Willkommen, Catherine M. Cahill, Yongjuan Xin, (unknown), Yanyan Liu, Adam Southon, Allegra T. Aron, Ho Yu Au‐Yeung, Xudong Huang, Debomoy K. Lahiri, Fudi Wang, Ashley I. Bush, Gerald Wulf, Philipp Ströbel, Bernhard Michalke, Jack T. Rogers	65
14	Manganese causes neurotoxic iron accumulation via translational repression of Amyloid Precursor Protein (APP) and H-Ferritin 2018 ·PMC ·(unknown), Thorsten R. Doeppner, Desiree Willkommen, Catherine M. Cahill, Yongjuan Xin, (unknown), Yanyan Liu, Adam Southon, Allegra T. Aron, Ho Yu Au‐Yeung, Xudong Huang, Debomoy K. Lahiri, Fudi Wang, Ashley I. Bush, Gerald Wulf, Philipp Ströbel, Bernhard Michalke, Jack T. Rogers	2
15	CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas 2017 ·Clinical Cancer Research ·Vivek Venkataramani, Stefan Küffer, Kenneth Cheung, Xuejun Jiang, Lorenz Trümper, Gerald Wulf, Philipp Ströbel	37
16	Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone 2015 ·Clinical Cancer Research ·Raphael Koch, Thiha Aung, Daniel Vogel, Bjoern Chapuy, Dirk Wenzel, Sabrina Becker, (unknown), Vivek Venkataramani, (unknown), Ralf Jacob, Lorenz Truemper, Gerald Wulf	109
17	Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens 2014 ·Leukemia ·Karin Hohloch, Samira Zeynalova, Gerhard Held, Marita Ziepert, Markus Loeffler, Gerald Wulf, Norbert Schmitz, Michael Pfreundschuh, Lorenz Trümper, (unknown)	5
18	[Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives]. 2006 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Gerald Wulf, Bjoern Chapuy, Lorenz Trümper	17
19	Pneumocystis carinii pneumonia with peripheral nodular infiltrates in a patient with T-acute lymphoblastic leukemia. 1998 ·Journal of Clinical Oncology ·Gerald Wulf, Utz Reichard, B. Wörmann, Wolfgang Hiddemann	3
20	Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells 1996 ·Annals of Hematology ·Gerald Wulf, (unknown), Frank Strutz, (unknown), M. Hüfner, Christian Buske, Bernhard Wörmann, Wolfgang Hiddemann	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact